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Summary: The possible role of thyroid hormones in the Nitric Oxide (NO)- mediated response to sexual 
stimulation, and on prostaglandin E1 (PGE1) and Sildenafil in the treatment of erectile dysfunction was 
investigated using the corpus cavernosum of the New Zealand rabbit animal model.  The parameters 
studied were penile erection monitored as contractile force of the erectile tissue, sperm count and 
motility; in parallel with the haematocrit, red cell count or rheology, Heart Rate (HR), Mean Arterial 
Pressure (MAP), Thyroid Stimulating Hormones (TSH) and Thyroixine levels.  Hypothyroidism or 
thyroidectomy was found to cause depletion of Endothelium Derived Relaxant Factor (EDRF) thereby 
causing very feeble contraction of the cavernosum muscle, in both Prostaglandin E1 (PGE1) and 
Sildenafil, oligospermia and less than 45% motile sperms.  Thyroxine treatment produced contraction 
proportionate to the concentrations of PGE1 and Sildenafil; providing evidence that the erectogenic 
actions of both PGE1 and Sildenafil are possible only in the presence of adequate thyroid hormone level.
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Introduction 
Erectile dysfunction is a known cause of 
impotence abnormal however, erectile 
dysfunction, impotence and abnormal sperm 
morphology can cause infertility. Padma-
Nathan et al (2001) found that erectile 
dysfunction is associated with behavioural risk 
factors like cigarette smoking, excessive intake 
of alcohol and other age-related medical 
conditions. Rajfer et al (1992) have reported 
phosphodiesterase – type 5 (PGE5) to be a 
critical component of the Nitric oxide-cyclic 
Guanidine Monophosphate (NO-cGMB) 
signaling pathway responsible  for the 
modulation of smooth muscle tone in the penis. 
The authors noted that inhibition of PGE5
magnifies the NO-mediated response to sexual 
stimulation, increasing intracellular 
concentrations of cGMP and thus maintaining 
penile erection.  Sildenafil, an inhibitor of PDE5
is an  effective treatment for erectile 
dysfunction (Padma-Nathan et al, 1998; 
Goldstein et al 1998, Dinsmore et al 1999). The 
inhibition of PDE5 would therefore be expected 
to result in improved contractile force.
Prostaglandin E1 (PGE1) solutions for 
intravenous injection therapy have been 
reported to be superior or at least equal in 
efficiency when compared to other erectogenic 
agents (Lea, Bryson and Baffour, 1996). The 
problem of erectile dysfunction is still prevalent 
despite attempts by scientists to find a total cure 
for it. The subject therefore calls for further 
investigations to find out if the problem could 
be due to enzyme or hormonal malfunction, its 
imbalance or deficiency. The present 
investigation examines any possible role of 
thyroid hormone (T4) in the  erectile or 
contractile activity of the rabbit corpus 
cavernosum treated with PGE1 and with 
Sildenafil. It has been stated that the most 
important chemical mediator of cavernosal 
relaxation is Nitric oxide (NO), released 
directly from nonadrenergic noncholinergic 
(purinergic) nerve endings and from 
endothelium (Utkan et al, 2001).
Hence, the need to inhibit EDRF to asses 
whether the thyroid hormone could have any 
role in the tonic or contractile response of the 
erectile tissue in the animal models: Euthyroid 
control, Hypothyroid (T); Hyperthyroid (TT), 
throidectomized rabbit with subsequent 
thyroxine replacement (TTT).
Materials and Methods
Sexually mature male New Zealand 
Rabbits of weight range 2.5-3kg and inbred at 
University of Jos Animal house were randomly 
placed into four groups: Group 1 or control (C). 
Group 2 or Thyroidectomized (T); Group 3 or 
Thyroidectomized Rabbits with subsequent 
thyroxine treatment (TTT) and Group 4 or 
Thyroxine-treated animals (TT). There were ten 
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rabbits in each group and the groups were 
matched weight for weight.
Preparation of Animals
Thyroidectomized  Rabbit: The animals 
were first anaesthetized as applied by Utkan et 
al(2001): Xylazinee 5mg/kg body weight and 
Ketamine 20mg/kg (Sigma Chemical St. Louis. 
MO. USA) were given intramuscularly to each 
rabbit. As soon as the anesthesia took effect the 
animals were prepared for surgery. The hair at 
the site of the operation was shaved and 
disinfected. A skin incision  of about 4cm in 
length was made with a scalpel in the midline 
axis of the neck. The wound was dilated with 
blunt forceps until the thyroid gland was 
exposed. The muscles and other adhering tissue 
were separated from the gland and then using a 
thermocautery the gland was removed; while 
leaving the external parathyroids intact. The 
wound was carefully swabbed and 
sulphonomide introduced into it. The skin was 
then stitched with interrupted sutures, which 
were knotted securely. Postoperative treatment 
include the administration of prophylactic 
procaine-penicillin injection intraperitoneally 
for 5 days. After surgery the rabbits were fed on 
normal rabbit pellets for 60 days while tap 
water was allowed ad-libitum.
Throidectomized Rabbits Treated with 
Thyroxine (TTT)
This group underwent the same surgical 
process as described for the thyroidectomized 
rabbits. In addition the animals received par 
oral, constant dose of thyroxine (A.H Cox and 
Co. Ltd Barstaple England); 10g/kg body 
weight for 60 days. The thyroxine tablets were 
taken in tepid water on a hot plate, to bring the 
tablets into solution. By means  of 1ml syringe 
attached to a canula, the dose was delivered 
dropwise around the oropharynx. This was 
effected by holding the upper incisors with a 
loop of strong thread tied to a water tap while 
the lower incisor teeth were held back by 
another loop tied to the thumb. After each 
administration of thyroxine the animals were 
also fed rabbit pellets and tap water allowed ad 
libitum for 60 days.
Thyroxine-Treated Rabbits (TT)
Thyroxine was administered at the same 
dose and method used for (TTT) to the group of 
euthyroid rabbits. They were similarly fed 
rabbit pellets and tap water for 60 days.
Control Rabbits
The animals in this group were given 
rabbit pellets and tap water was also allowed 
ad libitum for 60 days.
Contractile Studies. The preparation of the 
tissue for contractile studies was similar to the 
method applied by Utkan et al (2001).  The 
Corpora Cavernosa tissue comprissing four 
strips of corpus Cavernosum smooth muscle of 
each rabbit, euthanized by stunning, were 
dissected out of the penis; having made a 
ventral incision on the right and left corpora, to 
dissect the tunica.
From the corpus cavernosum tissue strips 
measuring 2 x 2 x 15mm were studied under 
standard organ baths conditions: The strips 
were mounted vertically with silk thread 
between a fixed metal base on one end in a 
20ml jacketed organ bath containing 10ml of 
physiological salt solution of the following 
composition (mMol/L): NaCl, 119.0, KCl 4.7,  
KH2 PO4 1.2, Mg  SO4 1.2, NaHCO3 24.9 CaCl2 
1.6 glucose 11.5.  The other end was connected 
to isometric force transducers (Grass FT. 03 
Quincy, M.A).  The temperature of the bath was 
maintained at 370C by a thermostatically 
controlled water bath. The solution was bubbled 
with 95% O2: 5% CO2 gas mixture; pH 7.40. 
Change in isometric force was recorded on a 
Grass Model 7, 8–channel Polygraph pen 
recorder (Grass Instruments Ltd. Quincy Mass). 
During a 90 min equilibrium period, the tissue 
was exposed to three changes of Kreb’s 
bicarbonate and resting tension adjusted to 2g, 
found to be optimal for measurement of 
changes in tension of rabbit corpus cavernosal 
preparation (Utkan et al (2001).
The strips except (T) were exposed for 
15 mins to 10M NG Monomethyl L-arginine 
(L-NMMA) a specific inhibitor of Nitric Oxide 
(NO) synthesis as applied by Ebeigbe and 
Aloamaka. (1999) and Aloamaka et al, (1999).  
This endothelium-derived relaxing factor (NO) 
has been reported to regulate vascular and 
smooth muscle tone (Kin et al, 1995; Rajfer et 
al, 1992; Obiefuna et al 1993. Lot and Wilson, 
1992, Lot 1993). After exposure to L-NMMA 
the strip of Corpora Cavernosa were then 
subjected in groups in turn to graded doses of 
PGE1 and Sildenafil (10
-6 – 3 x 10-4 M) in a 
cumulative manner.Contractile, responses in the 
four thyroid states: Control, Thyroidectomized. 
Thyroidectomized – treated with thyroxine, and 
Thyroxine treated, were recorded.
Semen Analysis 
Semen examination was performed for 
sperm count and motility. To collect the Semen 
a rubber condom containing warm semen 
diluting fluid was quickly slipped on to the base 
of the penis of each rabbit, as soon as it 
protruded the penis, to mount a sexually mature 
female presented to it in a large cage.  
Composition of Semen diluting Fluid (Baker et 
al, 1994) was Sodium Bicarbonate -5g, 
Formalin -2cm3, and distilled water -100cm3.
Sperm Count:
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The technique employed was similar to that 
for counting blood cells on an improved 
Neubauer chamber. The sample was well mixed 
and a dilution made as for red blood cell count 
using the sperm diluting fluid. The chamber 
was charged and placed on a warm-stage 
microscope. After being allowed to settle, the 
heads of spermatozoa in the large corner 
squares and the entire central square were 
counted.
Calculation:
Let N = No of sperm counted in 5 large 
squares, Then N/5 = No of sperm in 1sq mm,  N 
/5x 10 = No of sperm in  1mm3
This result multiplied by dilution 
factor (1/200) = No of sperm per mm3 of 
semen. The number of sperm per mm3 was as 
multiplied by 1.000 to obtain the number per 
cm3. Again this figure was multiplied by the 
total volume of semen expressed in cm3 to 
obtain the number of sperm per ejaculate.
Motility 
A cover-glass preparation in 
physiological saline was made to examine for 
motility. The slide was kept in an incubator at 
360C immediately before examination on a 
warm stage microscope set at 340C.
The types of motility were classified as:
1. Oscillatory or stationary hunting: the 
sperm do not move from place to place.
2. Undulating movement: with slow 
progression
3. Rapid, progressive, vibrating movement
The system adopted for comparing degrees of 
motility was: 0= No discernible motility.; 
1=Less than 50% motile, mostly weak and 
oscillatory; 2= More than 50% motile, 
vigorous, rapid waves or eddies; 3= 90% 
motile, rapid waves and eddies.
4= 90% motile, rapid waves and eddies; =100% 
motile, waves and eddies extremely rapid.
Counts In Sildenafil-Treated and Pge1-Treated 
Semen Fluid
Count and Motility in the four states were 
repeated in semen fluid containing 0.05mm3 of 
Sildenafil and another treated with the same 
volume of PGE1.
Statistics 
All results are expressed as Means  SEM, 
Statistical comparisons between the 
experimental groups were performed using the 
students’ two-tailed test for unpaired data.
Results 
Contractility: Contractile responses (in 
PGE1 and in sildenafil are shown in Figures 1 
and 2) highlight the following. Thyroid 
hormones or thyroxine treatment produced 
robust constrictor actions without 
preconstriction after de-endotheliazation, 
suggesting thyroid hormone as an endogenous 
excitatory factor mediating constrictor actions 
of arginine analogues in vessels and corpus 
cavernosum smooth muscle. This was strongly 
indicated by the non-response of PGE1 in 
thyroidectomy. Both thyroxine treatment and 
thyroxine replacement after thyroidectomy 
exhibited identical response as control at a 
concentration of 2.4 x 10-5 M/L, thus 
prescribing the maximum beneficial dose in 
thyroid hormone treatments, for erectile 
function.
A similar safety margin is shown in Figure 
2 by thyroxine treatment and control copora 
cavernosa graphs manifesting identical profile 
in sildenafil treatment. Contraction in 
thyroidectomy on  the contrary was just lifted 
from  the base line, depicting sildenafil action 
to be dependent on thyroid hormone level in the 
vicinity of the erectile tissue of the rabbit penis.
Table 1: Semen Analysis of Experimental Rabbits in Thyroidectomy and Thyroxine. Treatment. Sperm Count Mean 
(X) ± SEM (X106mm-3).
Animal 
Group:
C T TTT TT P-Value
141 151 140 151 CV*T
112 8 125 185 <0.001
186 10 200 120 CV*TTT
125 12 115 130 <0.5
102 14 125 111 CV*TT
191 75 150 80 <0.5
89 28 95 95 TTV*T
150 9 108 170 <0.001
145 50 115 65
110 30 145 80
X 136.1±10.9 25.1±6.0 121.8±14.97 116.9±12.9
Key C = Control: T = Thyroidectomized: TT = Thyroxine-treated: TTT = thyroidectomized-treatment with 
thyroxine. Number of animals in parenthesis, P<0.05 significant. Student t –test P<0.001. n=10
Thyroid Hormone repairs Erectile Dysfunction 85
Table 2: Semen Analysis of Experimental Rabbits in Thyroidectomy and Thyroxine. Sperm Motality 
Mean X ± SEM (%).
Animal 
Group: 
C T TTT TT P-Value
3 0 2 4 CV*T
2 1 2 5 CV*
4 2 3 3 CV*TTT
5 0 4 3 .0.5
3 1 4 4 CV*TT
X 3.4±0.5
0
*0.8±0.37 3±0.5 3.8±0.4 <0.5
 C = Control: T = Thyroidectomized: TTT = Thyroidectomized treated with thyroxine TT thyroxine 
treated Number of animals are in parenthesis. Scoring Scale = 0-5; 0 = No discernible motility: 1-50% 
motility, mostly weak and oscillatory; 2 50% motility. Vigorous. Rapid without waves or eddies: 3 75% -
85% motile, vigorous waves and eddies: 5 = 100 motile, waves and eddies extremely rapid ,  P<0.05 as 
statistically significant n=5.
Tables 1, 2 ,3, and 4 show that there was no 
significant difference in sperm count between 
control and thyroxine-treated rabbit whereas the 
difference exists between control and 
hypothyroid (thyroidectomized) rabbits (P< 
0.001): and the same P-value between the two 
groups in sperm motility. There are also 
differences at P<0.025 in red blood cell count 
and heart rate. There were no significant 
differences in haematocrit, mean arterial blood 
pressure (MAP); and Thyroxine (T4) levels 
between each group and control. However, 
difference exist between Thyroxine treated (TT) 
and Thyroidectomized (T) rabbits in 
haematocrit, MAP and Heart Rate (HR), levels 
at (P<.0.05). TSH for control and TT were also 
statistically different.
Table 3: Haematocrit, Red Blood Cell Count and mean Arterial Pressure of Experimental 
Rabbit Mean X SEM
Experimental 
Animals
Haematocrit (%) Red Blood Cell (x106) mm-3 Mean Arterial Pressure 
(mm112)
C T TTT TT C T TTT TT C T TTT TT
1 41 34 40 42 5.4 2.2 4.8 6.5 20 15 21 22
2 40 25 38 40 4.9 3.4 5.0 7.0 2.5 14 19 20
3 42 30 40 41 5.0 4.0 5.8 20 20 15 20 21
4 39 38 41 42 5.2 3.0 5.0 6.0 20 16 16 20


















21.01± 11.01± 11.01± 2.161±
C = Control: T = thyroidectomized; TTT = Thyroidectomized-treated with thyroxine, TT = Thyroxine-
treated Number of animals in parenthesis. CV*T, P<0.001 for Haematocrit, CV*T & P<0.001 for RBC
V* = Compared with, P<0.05. (n=5)
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Table 4: Show  Heart Rate, TSH & T4 Levels of Experimental Animals Mean XSEM
Experimental 
Animals
Heart Rate (beasts per minute)
 C               T            TTT        TT
Thyroid Stimulating Hormone 
(TSH) (u.ml)
 C             T            TTT       TT
Thyroxine (T) ng/Dl
C          T        TTT     TT
P-Value
1      (10) 148 136 150 149 6.5 1.8 5.6 .82 3.8 0.6 2.5 4.8 Heart Rate 
CVsT:.
P<0.001
2     (10) 140 130 145 140 5.4 1.0 6.7 6.6 4.0 0.6 1.9 1.0
3     (10) 145 135 140 142 6.0 0.7 6.0 5.8 3.5 0.5 4.2 2.2 CVsTT:
P<0.50
4     (10) 150 140 150 160 4.8 1.6 5.5 5.0 3.0 0.8 1.5 3.5 FOR TSH
6     (10) 145 120 138 140 5.8 0.8 4.5 6.8 2.8 0.5 2.0 4.0 CVsT:
.P<0.001

































C = Control; T = thyroidectomized; TTT = Thyroidectomized, treated with thyroxine, TT = Thyroxine –
treated. Number of animals in parenthesis. Regard P<0.05 as significant, Vs = compared with 
*P<0.001; **P<0.01.
Discussion 
There are interesting findings in the present 
work, in hypothyroidism or thyroidectomy; 
there was no contraction of the vas deferens in 
PGE1 despite inhibition of Endothelium 
Derived Relaxation Factor (EDRF) by  10M 
NGL – NMMA. There was delayed but feeble 
short-lived contraction or increase in tone of the 
corpus cavernosum, the inhibition of PDE5 by 
sildenafil not withstanding (figures 1&2).
In spite of these inhibitions, thyrroxine (T4) 
treatment in the affected groups gave robust 
contractions proportionate to the concentration 
of PGE1 and sildenafil respectively. Work on 
prostaglandin E2 (PGE2), an analogue of PGE1
had shown its contraction of the vas deferens 
smooth muscle to be dependent on the thyroid 
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Fig. 1: Responses of Vasa deferentia in various thyroid states to PGE1              
following inhibition of Nitric oxide.
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In the present investigation the muscle tone 
produced by PGE1 in thyroxine treatment and 
the lack of contraction in thyroidectomy suggest 
that thyroxine is implicated in the erectogenic 
activity of PGE1. It would also appear that the 
endogenous excitatory factor mediating the 
constrictor actions of arginine analogues and 
prostaglandin E1 is thyroid hormone.
It is noteworthy that the responses were 
low inspite of thyroxine treatment (TTT). This 
was probably because, after removal of the 
thyroid gland, there was bound to be 
contraction hysteresis before thyroxine 
rehabilitation took effect within he time of 
study. The group had to depend on the 
secondary organs like salivary glands and 
gastric mucosa for trapping iodide for T4
formation.
In hypothyroidism the non-contractile 
responses of the erectile tissue neither treated 
with EDRF inhibitor non-with sildenafil, an 
inhibitor of PDE5, were similar to response after 
the inhibitions. It is probable then that 
thyroidectomy or hypothyroidism depletes 
EDRF and thus inhibits the Nitric Oxide-cGMP 
pathway or potentiates PDE5 action. Sildenafil 
did not also produce increase in tone or tension 
of the hypothyroid  rabbits.
Thyroxine on the other hand appears to 
inhibit PDE5 to activate the NO-cGMP 2nd 
messenger probably involving the thyroid 
adenyl cyclase by linking to the regulatory G-
protein. Thus the effectiveness of sildenafil 
from this study, in inhibiting PDE5 appears 
dependent on thyroid hormone.
As penile erection is a haemodynamic 
process involving relaxation of smooth muscle 
of Corpus cavernosum, depletion of EDRF by 
hypothyroidism could be responsible for the 
feeble contraction or non-relaxation of the 
muscle due to rigidity. Hypothyroidism has 
been reported to cause muscular atony 
(Goldstone and Ford, 1995: Amadi et al 1999). 
Thus, the lack of, or low tone prevents 
increased  flow of blood into the trabecular 
spaces  of the corpora cavernosa, to increase  
the vascular and muscle tone. The corporeal 
smooth muscle tone is important in the control 
of erection (Crist, 1995, Goldstein and Berman, 
1998). This observation was represented by 
lower red blood cell count or quantity of blood 
flow, and motility in  thyroidectomy, which 
impaired EDRF, which in turn is a major 
contributor to erectile dysfunction. These 
occurred with non-significant differences in T4
and MAP in all the groups, but TSH in TT.
It would  be reasonable to conclude from 
the results of the present investigation  that 
thyroid hormone is implicated in the activation 
of PGE1 and inhibition of PDE5 by Sildenafil. 
The erectogenic actions of PGE1 and sildenafil 
are thyroid dependent. It would thus be a very 
important factor for ameliorating eretile 
dysfunction.  Erectile dysfunction parameters or 
tests should take cognizance of the thyroid 



























Fig.2: Responses of erectile tissue of rabbit penis to sildenafil.
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as observed presently that hypothyroidism 
(thyroidectomy) could be a factor in erectile 
dysfunction through the mechanism of de-
endothelization or depletion of  Endothelium -
Derived Relaxation Factor (EDRF).
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